If you are a nurse practitioner in a state that requires a physician collaborator, you have probably calculated the math at least once: what does a collaborative practice agreement actually cost, does it constrain what you can prescribe, and is the lost autonomy worth staying for? For some NPs, the answer is to relocate. For most, it is more complicated than a state ranking chart suggests.
This guide lays out what practice authority tiers mean in concrete, daily practice terms — and walks through the actual decision framework for whether moving states makes financial and professional sense for your situation.
Quick-scan summary
| Tier | What it means | Examples |
|---|---|---|
| Full practice authority (FPA) | NP practices, prescribes, and bills independently | Oregon, Washington, Colorado, Minnesota, most western states |
| Reduced practice | NP can practice independently but requires physician collaboration for prescribing or specific services | Illinois, Michigan, New York (partially), others |
| Restricted practice | Physician supervision required for practice and/or prescribing | California, Florida, Georgia, Texas (partially) |
The practical question is not which tier your state falls into, but whether the restrictions your state imposes are limiting your specific specialty and patient population enough to matter.
The three practice authority tiers
Full practice authority
Full practice authority (FPA) means an NP can evaluate, diagnose, treat, and prescribe — including controlled substances with a DEA registration — without any required physician involvement. You may consult with physicians voluntarily, as you would in any clinical environment, but there is no mandated oversight structure and no collaborative practice agreement required.
The American Association of Nurse Practitioners (AANP) maintains the definitive state-by-state map. As of 2025–2026, FPA states include Alaska, Arizona, Colorado, Connecticut, Hawaii, Idaho, Iowa, Kansas, Maine, Maryland, Minnesota, Montana, Nebraska, Nevada, New Hampshire, New Mexico, North Dakota, Oregon, Rhode Island, South Dakota, Vermont, Washington, Wyoming, and the District of Columbia. Florida moved to FPA in 2023 under a phased implementation for new graduates.
The list grows most years. States that granted FPA in the last several years include Ohio, Kentucky, and Indiana, which historically were among the most restrictive.
Reduced practice
Reduced practice states allow NPs to practice independently in most respects but require a collaborative practice agreement (CPA) with a physician for certain prescribing functions or supervisory sign-offs. The exact structure varies: some states require a CPA only for Schedule II–IV controlled substances, others require it for all prescribing, and others structure it around specific clinical contexts.
Illinois, Michigan, and parts of New York’s outpatient practice environment fall into this category, though the specifics evolve as state legislatures update their nurse practice acts.
Restricted practice
Restricted practice states require active physician supervision for NP practice — a higher bar than a CPA. In California, for example, NPs can achieve FPA after meeting specific clinical experience requirements (as of SB 890, signed 2020), but the transition timeline and employer compliance have been uneven. Texas allows a degree of NP autonomy in certain settings while maintaining supervisory requirements in others. Georgia requires a physician protocol agreement for all NP prescribing.
These distinctions matter because state law sets the floor, but employer contracts, credentialing requirements, and hospital bylaws can layer additional restrictions on top. Even in FPA states, a health system may require physician co-signatures on certain orders.
What prescriptive authority restrictions actually affect
The daily practice impact of a CPA or supervisory requirement depends heavily on what you prescribe and where you work.
DEA Schedule II–V controlled substances
Schedule II drugs — opioid pain medications, stimulants (Adderall, Ritalin), certain sleep aids — are where restrictions bite hardest. In reduced or restricted practice states, prescribing Schedule II substances typically requires either the physician’s co-signature or the physician’s DEA number, depending on the state.
For psychiatric NPs, this is a significant constraint: first-line ADHD medications are Schedule II, many antidepressants are co-prescribed with benzodiazepines (Schedule IV), and some states restrict NP authority to initiate buprenorphine (Schedule III) for opioid use disorder treatment. A psychiatric NP in a restricted state may be managing patients with conditions where the most effective medications require a physician’s involvement in every prescription.
For a primary care NP in a low-acuity adult population, the Schedule II exposure may be limited — you are prescribing mostly antibiotics, antihypertensives, and statins, none of which are controlled. The CPA costs you money and administrative time but does not limit your clinical scope meaningfully.
Collaborative practice agreement: what it costs
A CPA is a contract with a physician who agrees to supervise or collaborate on your practice. The physician does not work beside you — they review charts periodically, sign off on protocols, and are available for consultation. In low-restriction states, this may be largely nominal. In high-restriction states, it may require regular chart reviews and co-signatures.
The cost ranges significantly by state and specialty:
- In states where CPAs are common and well-established, established NPs can sometimes negotiate a CPA as part of an employment package (employer absorbs the cost and coordinates the physician relationship)
- Independent NPs and practice owners typically pay directly: $500–$5,000 per year, depending on the physician’s specialty, demand for CPA arrangements in the area, and what the agreement covers
- Rural markets often have higher CPA costs because fewer physicians are available to serve as collaborators, creating leverage
Beyond the dollar cost, the CPA creates operational dependency: if your collaborating physician retires, moves, or chooses not to renew, you need to find a new one. In specialties with physician shortages, this is a real operational risk.
Specialties most affected
Psychiatric mental health NPs (PMHNPs): The most directly affected specialty. Schedule II prescribing is central to psychiatric care — stimulants for ADHD, sometimes amphetamines for treatment-resistant depression. Buprenorphine for OUD treatment requires a DATA 2000 waiver and, in some restricted states, physician co-management. A PMHNP trying to build an independent outpatient psychiatry practice in a restricted state faces layered barriers that an FPA state removes entirely.
Primary care NPs in rural areas: Rural primary care NPs often serve populations with no other provider. In restricted states, the requirement for physician oversight can create a practical contradiction: the NP is the only provider in the county, but must have a physician collaborator who may be 60 miles away. Rural health advocates have used this as a key argument for FPA expansion. If you are considering rural primary care, the state’s practice authority tier is a critical site selection factor.
Pain management NPs: Heavy Schedule II prescribing exposure. CPA requirements create significant friction in states where the physician needs to co-sign Schedule II scripts or be named on prescriptions.
Acute care and hospital-based NPs: Often less affected by state FPA tiers than outpatient NPs. Hospitals operate under credentialing systems that layer physician oversight regardless of state law, and the employer typically absorbs the cost of any required agreements. Restrictive state law matters more for independent and outpatient practice.
The relocation calculation
Moving to an FPA state eliminates the CPA cost and removes the prescriptive authority constraint. Whether that trade makes financial sense depends on your specific practice situation.
Arguments for relocation:
- You are an independent practice owner and paying $2,000–$5,000/year in CPA costs that come directly out of your income
- Your specialty involves significant Schedule II prescribing and the CPA creates clinical friction, delays, or limits your scope in ways that affect patient outcomes
- Your state is genuinely not moving toward FPA (some southern states have shown little legislative movement on this)
- The target state has comparable or better reimbursement rates, and housing/cost of living differences are manageable
Arguments against relocation:
- Your employer absorbs all CPA costs and coordinates the physician relationship — your take-home pay and daily scope are not actually affected
- Your specialty has minimal Schedule II prescribing exposure and the CPA is an administrative inconvenience rather than a clinical limitation
- Your state is in active legislative transition toward FPA (several states have passed FPA legislation in the last three years; your state may be next)
- Your professional network, family roots, or cost of living in your current state create relocation costs that outweigh the practice authority benefit
The financial model: If your CPA costs $3,000/year and relocating to an FPA state allows you to operate more efficiently, eliminate those fees, and bill independently for services previously shared, the break-even on relocation costs (licensing, moving, potentially different housing costs) is a two- to four-year horizon for most NPs. That may be worthwhile for career-stage NPs with 20+ years ahead. For someone 10 years from retirement, the math is harder to justify.
Licensing by endorsement: what relocation requires
Relocating to a new state requires obtaining a new NP license and typically re-credentialing with any new employers or insurance panels. The process is called licensure by endorsement — most states accept an active RN license from another state without re-examination, but NP licensure requires separate application and verification.
Key logistics:
- Timeline: 4–12 weeks depending on the state’s board processing time; expedited processing is available in some states for an additional fee
- Primary source verification: your nursing school, NCLEX results, and any prior state board actions are verified directly with the originating institutions
- NPI number: your NPI is national and does not change with state relocation, but your state license numbers will be different
- DEA registration: DEA registration is state-specific. Relocating requires a new state DEA registration ($888 for a three-year term as of 2024)
Resources for researching a target state: the NCSBN (National Council of State Boards of Nursing) publishes detailed state-by-state practice profiles at ncsbn.org. The AANP state practice environment map provides a current tier classification and links to each state’s nurse practice act.
For career-stage context on whether the NP credential is worth pursuing first, see is the RN-to-NP path worth it?. For an overview of NP employment settings by practice type, see NP employment settings. For a guide to FPA states specifically, see nurse practitioner independent practice states.